Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2 (Q11029)

From Wikibase.slis.ua.edu
Revision as of 14:33, 22 June 2020 by Admin (talk | contribs) (‎Created claim: Property:P105: 41-48, #quickstatements; #temporary_batch_1592836326594)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
Language Label Description Also known as
English
Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.

    Statements

    title
    Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells (English)
    0 references
    Publication Date
    2004
    0 references
    First Author string
    Traebert M
    0 references
    Second Author string
    Dumotier B
    0 references
    Third Author string
    Meister L
    0 references
    Fourth Author string
    Hoffmann P
    0 references
    Fifth Author string
    Dominguez-Estevez M
    0 references
    Sixth Author string
    Suter W
    0 references
    Published In Name String
    Eur J Pharmacol
    0 references
    PubMed ID
    14729380
    0 references
    Volume
    484
    0 references
    Page(s)
    41-48
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q11029&oldid=221994"